Word

TERREMOTO

Status

Pending

Status Code

731

Status Date

Tuesday, August 13, 2024

Serial Number

97035820

Mark Type

4

Filing Date

Monday, September 20, 2021

Published for Opposition

Tuesday, June 20, 2023

Trademark Owner History

TERREMOTO BIOSCIENCES, INC. - Owner At Publication
Seismic Medicines, Inc. - Original Applicant

Classifications

5 pharmaceuticals for the prevention and treatment of cancer, oncological diseases, disorders and conditions; pharmaceuticals for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; pharmaceutical preparations and substances for the prevention and treatment of cancer, oncological diseases, disorders and conditions;pharmaceutical preparations and substances for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; biopharmaceuticals for the prevention and treatment of cancer, oncological diseases, disorders and conditions; biopharmaceuticals for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; medicines for the prevention and treatment of cancer, oncological diseases, disorders and conditions; medicines for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; drugs for the prevention and treatment of cancer, oncological diseases, disorders and conditions;drugs for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; drug compounds for the prevention and treatment of cancer, oncological diseases, disorders and conditions;drug compounds for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; small molecules for the prevention and treatment of cancer, oncological diseases, disorders and conditions;small molecules for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions; therapeutics for the prevention and treatment of cancer, oncological diseases, disorders and conditions;therapeutics for the prevention and treatment of genetic, inflammatory, infectious, viral, immune system, immunological, autoimmune, blood, hematologic, ophthalmological, cardiovascular, cardiopulmonary, metabolic, kidney, liver, vascular, endocrine, and dermatologic diseases, disorders and conditions

The English translation of "TERREMOTO" in the mark is "earthquake".

Trademark Events

Apr 5, 2022

Non-Final Action Written

Sep 23, 2021

New Application Entered

Oct 23, 2021

New Application Office Supplied Data Entered

Mar 25, 2022

Assigned To Examiner

Apr 5, 2022

Non-Final Action E-Mailed

Apr 5, 2022

Notification Of Non-Final Action E-Mailed

Jun 23, 2022

Automatic Update Of Assignment Of Ownership

Oct 5, 2022

Teas Response To Office Action Received

Oct 5, 2022

Correspondence Received In Law Office

Oct 6, 2022

Teas/Email Correspondence Entered

Nov 16, 2022

Final Refusal Written

Nov 16, 2022

Final Refusal E-Mailed

Nov 16, 2022

Notification Of Final Refusal Emailed

Jan 25, 2023

Automatic Update Of Assignment Of Ownership

May 11, 2023

Examiners Amendment -Written

May 11, 2023

Examiners Amendment E-Mailed

May 11, 2023

Notification Of Examiners Amendment E-Mailed

May 11, 2023

Examiner's Amendment Entered

May 11, 2023

Approved For Pub - Principal Register

Jun 20, 2023

Published For Opposition

May 31, 2023

Notification Of Notice Of Publication E-Mailed

Jun 20, 2023

Official Gazette Publication Confirmation E-Mailed

Aug 15, 2023

Noa E-Mailed - Sou Required From Applicant

Feb 9, 2024

Sou Teas Extension Received

Feb 9, 2024

Sou Extension 1 Filed

Feb 9, 2024

Sou Extension 1 Granted

Feb 10, 2024

Notice Of Approval Of Extension Request E-Mailed

Aug 13, 2024

Sou Teas Extension Received

Aug 13, 2024

Notice Of Approval Of Extension Request E-Mailed

Aug 13, 2024

Sou Extension 2 Granted

Aug 13, 2024

Sou Extension 2 Filed